Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Corbus Pharmaceuticals Hldgs Inc (NQ: CRBP )

43.40 +1.01 (+2.38%)
Streaming Delayed Price Updated: 11:38 AM EDT, May 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Corbus Pharmaceuticals Hldgs Inc

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Bullish Wednesday For Marijuana Stocks - Global Hemp Group, SOL Glb Inv Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For February 26, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For February 21, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Is Corbus Pharmaceuticals (CRBP) Stock Up 300% Today?
Shares of Corbus Pharmaceuticals are absolutely skyrocketing today, with CRBP stock now up more than 300% on the day. 
Via InvestorPlace
Marijuana Stock Movers For February 15, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For February 14, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Thursday For Marijuana Stocks - ESCO Technologies, Global Hemp Group Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
The 3 Most Undervalued Biotech Stocks to Buy in February 2024
With patience, some of the most undervalued biotech stocks can create massive wealth, such as these three to consider. 
Via InvestorPlace
Cannabis Stock Movers For February 7, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For February 2, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
What's Going On With Cancer-Focused Corbus Pharmaceuticals Stock Today?
Corbus Pharmaceuticals announces a $82.2M public offering at $19.00 per share. Explore latest updates on CRB-701 clinical study. 
Via Benzinga
Cannabis Stock Gainers And Losers From January 31, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
$16.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades. 
Via Benzinga
Why Corbus Pharmaceuticals Shares Are Gaining Today
Yesterday, after the markets closed, Corbus Pharmaceuticals announced that it plans to offer and sell shares of its common stock or, in lieu of common stock to certain investors, pre-funded warrants to... 
Via Benzinga
Cannabis Stock Gainers And Losers From January 30, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For January 29, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) shares rose sharply in today's pre-market trading after Jefferies upgraded the stock from Hold to Buy and raised its price target from $14 to $20. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning! 
Via InvestorPlace
Investors Take Note as Corbus Pharma Releases Data for ADC Tumor Candidate
--News Direct-- 
Via News Direct
Cannabis Stock Gainers And Losers From January 26, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Is Precision Oncology-Focused Corbus Pharmaceuticals Stock Trading Higher Today?
Corbus Pharma's CRB-701 exhibits 43% ORR and 71% disease control in urothelial cancer trial. 
Via Benzinga
Nasdaq Down Over 50 Points; Colgate-Palmolive Posts Upbeat Results
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling over 50 points on Friday The Dow traded up 0.05% to 38,069.66 while the NASDAQ fell 0.4% to 15,447.78. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Crude Oil Down 1%; American Express Shares Rise After Q4 Results
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 100 points on Friday. The Dow traded up 0.32% to 38,170.95 while the NASDAQ rose 0.10% to 15,525.24. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
US Stocks Mixed; Core PCE Prices Rise In December
U.S. stocks traded mixed this morning, following the release of PCE price inflation data. Following the market opening Friday, the Dow traded up 0.12% to 38,096.06 while the NASDAQ fell 0.19% to... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.